Symprove Ltd is a biotech startup with a mission to improve gut health using live bacteria. Since its launch in 2002, the company has garnered significant recognition, including the backing of medical professionals and scientists. Symprove's product stands out due to its water-based formula, allowing the billions of live bacteria to survive stomach acid and thrive in the gut, a fact supported by large independent trials, including one conducted at King’s College London where the product outperformed seven leading alternatives.
Endorsed by experts and valued by customers who report life-changing experiences, Symprove has achieved a 50% annual growth rate and has established a strong online community, offering support and informative content. The company's success aligns with the growing focus on the microbiome and wellness market. Despite this growth, Symprove remains committed to its core mission of enhancing daily comfort and promoting gut health for all.
There is no investment information
No recent news or press coverage available for Symprove Ltd.